Actively Recruiting
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Led by Shanghai Changzheng Hospital · Updated on 2023-11-13
182
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
S
Shanghai Changzheng Hospital
Lead Sponsor
P
Peking University Third Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this clinical trial is to explore the impact of En bloc surgery and separation surgery combined with radiation therapy on the prognosis and survival of patients with spinal oligometastatic cancer, describe the clinical results, and optimize future treatment goals
CONDITIONS
Official Title
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to sign written informed consent
- Age between 18 and 75 years, any gender
- Persistent uncontrollable pain, progressing metastatic lesions, spinal instability or risk of instability, or symptoms of spinal cord or nerve compression despite conservative treatment
- PET-CT shows no more than 3 metastatic organs and no more than 5 metastatic lesions in the whole body, including 1 to 5 spinal metastases
- Imaging tests (enhanced MRI, CT, X-ray) confirm spinal metastasis
- Expected survival time of at least 6 months
- No other surgical contraindications
You will not qualify if you...
- Primary spinal tumors or multiple tumors with more than 3 metastatic organs and more than 5 metastatic sites
- Previous spinal surgery or radiotherapy to the treatment area
- Severe heart, lung, liver, kidney, or other diseases that affect surgery
- Cognitive impairment, speech difficulties, or inability to understand basic instructions
- Participation in other drug or medical device trials within 3 months before enrollment
- Infectious diseases
- Refusal to follow up or participate
- Investigator's judgment that the patient is unsuitable for the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Changzheng hospital
Shanghai, Shanghai Municipality, China, 200003
Actively Recruiting
Research Team
J
Jianru Xiao, Doctor
CONTACT
W
Wei Xu, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here